1. Home
  2. LEGN vs LOAR Comparison

LEGN vs LOAR Comparison

Compare LEGN & LOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • LOAR
  • Stock Information
  • Founded
  • LEGN 2014
  • LOAR 2012
  • Country
  • LEGN United States
  • LOAR United States
  • Employees
  • LEGN N/A
  • LOAR N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • LOAR
  • Sector
  • LEGN Health Care
  • LOAR
  • Exchange
  • LEGN Nasdaq
  • LOAR NYSE
  • Market Cap
  • LEGN 7.8B
  • LOAR 7.6B
  • IPO Year
  • LEGN 2020
  • LOAR 2024
  • Fundamental
  • Price
  • LEGN $34.68
  • LOAR $76.32
  • Analyst Decision
  • LEGN Strong Buy
  • LOAR Strong Buy
  • Analyst Count
  • LEGN 13
  • LOAR 4
  • Target Price
  • LEGN $81.54
  • LOAR $85.50
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • LOAR 617.1K
  • Earning Date
  • LEGN 11-12-2024
  • LOAR 02-01-2025
  • Dividend Yield
  • LEGN N/A
  • LOAR N/A
  • EPS Growth
  • LEGN N/A
  • LOAR N/A
  • EPS
  • LEGN N/A
  • LOAR 0.20
  • Revenue
  • LEGN $520,183,000.00
  • LOAR $378,813,000.00
  • Revenue This Year
  • LEGN $120.77
  • LOAR $26.18
  • Revenue Next Year
  • LEGN $68.54
  • LOAR $22.97
  • P/E Ratio
  • LEGN N/A
  • LOAR $390.29
  • Revenue Growth
  • LEGN 122.96
  • LOAR 58.21
  • 52 Week Low
  • LEGN $32.66
  • LOAR $42.57
  • 52 Week High
  • LEGN $70.13
  • LOAR $96.99
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 32.71
  • LOAR N/A
  • Support Level
  • LEGN $40.97
  • LOAR N/A
  • Resistance Level
  • LEGN $43.96
  • LOAR N/A
  • Average True Range (ATR)
  • LEGN 2.03
  • LOAR 0.00
  • MACD
  • LEGN -0.72
  • LOAR 0.00
  • Stochastic Oscillator
  • LEGN 16.97
  • LOAR 0.00

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About LOAR LOAR HOLDINGS INC

Loar Holdings Inc in the design, manufacture, and sale of niche aerospace and defense components that are essential for today's aircraft and aerospace and defense systems. Its manufactured products includes auto throttles, lap-belt airbags, two- and three-point seat belts, water purification systems, fire barriers, polyimide washers and bushings, latches, hold-open and tie rods, temperature and fluid sensors and switches, carbon and metallic brake discs, fluid and pneumatic-based ice protection, RAM air components, sealing solutions and motion and actuation devices, among others. It operate across ten manufacturing facilities located in the United States, one manufacturing facility in Germany and one manufacturing facility in the United Kingdom (UK).

Share on Social Networks: